A new study published in the journal PLOS Medicine shows that the number of prostate cancer deaths could be reduced by a sixth by simply introducing targeted screening, which is directed at detecting cases among men whose genes put them at higher risk of the disease. The study employs computer modelling to evaluate the potential risk-benefit ratio of routinely screening all adult males aged 55-69 years for prostate cancer by a simple blood test every four years, vs only those who have a higher risk.
Prostate cancer danger medical concept illustration. Nearly one in six deaths from prostate cancer could be prevented if targeted screening was introduced for men at a higher genetic risk of the disease, according to a new UCL-led computer modelling study. Image Credit: Lightspring
PSA and prostate cancer
Prostate cancer is the most frequently diagnosed male cancer. In the UK, about 130 men are found to have the disease every day, and it claims over 10,000 lives a year. Screening for this disease is not yet part of any national program, though there are such programs for breast and cervical cancer.
A potential screening test for prostate cancer is ...